Sportradar Q3 2026: Revenue Up 24%, EBITDA Margin Hits 28.2%, Buybacks Accelerate

What happened

Sportradar reported Q3 2026 revenue of €363 million, up 24% year-over-year, with adjusted EBITDA increasing 21% to €102 million, yielding a margin of 28.2%, a significant expansion from prior periods. Net profit rose 20% to €27 million, though still only 7.5% of revenue, while operating cash flow surged 37% to €157 million and free cash flow increased 12% to €73 million, reflecting strong cash generation. The company repurchased US$157 million of shares during the quarter, signaling management's confidence and commitment to returning capital. Additionally, Sportradar agreed to divest Atrium Sports for US$170 million, streamlining its portfolio, and entered new partnerships with prediction market exchanges and brokers, tapping into a growing adjacent market. These results suggest that the integration of IMG ARENA is progressing without the feared rights "repair" costs, and the company is delivering on its margin expansion promises ahead of schedule.

Implication

The Q3 2026 performance, with 24% revenue growth and 28.2% adjusted EBITDA margin, exceeds the base case expectation of ~23% growth and 250 bps margin expansion, suggesting the IMG ARENA integration is adding value without the anticipated cost drags. The large share repurchase of $157 million in one quarter signals that management sees the stock as undervalued and has ample free cash flow to support returns, which could underpin the stock price. The divestiture of Atrium Sports for $170 million reduces complexity and provides additional liquidity, while the new prediction market partnerships open a new growth vector that could diversify revenue beyond traditional sports betting. However, net profit margin remains low at 7.5%, indicating that the company is still heavily reinvesting in rights and technology, and the full-year picture will depend on continued revenue momentum and cost discipline. Investors should monitor whether the margin expansion is sustainable and whether the prediction market initiatives gain traction, but the risk-reward has improved, and the stock may deserve a higher multiple if the trend continues.

Thesis delta

The Q3 2026 results materially strengthen the investment thesis by demonstrating faster-than-expected margin expansion and robust cash generation, reducing the integration risk that was a key concern. The base case seems validated and the probability of the bull case has risen, as the company is over-delivering on its 2026 framework. Litigation and control-related risks still warrant monitoring, but the evidence tilts the balance toward a more bullish stance, potentially upgrading the rating from POTENTIAL BUY to BUY if sustained.